![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 02, 2008 10:26:01 AM
The abstract for his particular presentation in the session is below-
Session Title:
Immune Evasion and Surveillance
Presentation Title:
Balancing tumor immunity and inflammatory pathology
Sunday, Apr 13, 2008, 4:40 PM - 5:00 PM
Location:
Room 6C, San Diego Convention Center
Author Block:
Glenn Dranoff. Dana-Farber Cancer Institute, Boston, MA
We demonstrated that vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony stimulating factor (GM-CSF) generates potent, specific, and long-lasting anti-tumor immunity in murine models through improved tumor antigen presentation by mature CD11b+ dendritic cells and macrophages. The coordinated activities of CD4+ and CD8+ T cells, CD1d-restricted invariant NKT cells, and antibodies accomplish protective immunity. Several Phase I clinical trials evaluating this immunization scheme in patients with disseminated tumors revealed the consistent elicitation in distant metastases of dense T and B cell infiltrates that effectuated substantial tumor necrosis and fibrosis. Moreover, the subsequent administration of a humanized blocking antibody against cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) accomplished additional tumor destruction with lymphocyte and granulocyte infiltrates in a majority of stage IV patients, in the absence of serious autoimmune toxicities. Detailed study of blood and tumor samples from patients on these trials revealed the induction of a broad cellular and humoral response to multiple tumor-associated antigens, including melanoma inhibitor of apoptosis protein (ML-IAP) and MHC class I chain-related protein A (MICA). Pathologic examination of tumor infiltrates following immunotherapy revealed a linear relationship between the extent of tumor necrosis and the natural logarithm of the ratio of CD8+ cytotoxic T cells to FoxP3 expressing regulatory T cells (Tregs).
Our recent investigations of GM-CSF deficient mice uncovered an unexpected critical role for this cytokine in Treg homeostasis. GM-CSF is required for the expression of the phosphatidylserine binding protein milk fat globule EGF-8 (MFG-E8) in antigen presenting cells, whereas the uptake of apoptotic cells by phagocyte-derived MFG-E8 stimulates peripheral Treg maintenance through TGF-β, MHC class II, and CCL22. In wild type mice, MFG-E8 limits the potency of GM-CSF secreting B16 melanoma vaccines through Treg induction, while a dominant negative MFG-E8 mutant (RGE) potentiates therapeutic immunity through Treg inhibition, resulting in the regression of established tumors. Together, these findings suggest that combinations of GM-CSF and MFG-E8 inhibition might improve the efficacy of cancer vaccines and complement the activity of CTLA-4 antibody blockade. Efforts to translate this combinatorial strategy involving MFG-E8 blockade into early stage clinical testing in advanced melanoma patients are underway.
------
For further info see my posts:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=27868131
http://investorshub.advfn.com/boards/read_msg.asp?message_id=27891121
j
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM